Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

Mian, Hira; Eisfeld, Christine; Venner, Christopher P; Masih-Khan, Esther; Kardjadj, Moustafa; Jimenez-Zepeda, Victor H; Khandanpour, Cyrus; Lenz, G; McCurdy, Arleigh; Sebag, Michael; Song, Kevin; LeBland, Richard; White, Darrell; Stakiw, Julie; Reiman, Anthony; Louzada, Martha; Aslam, Muhammad; Kotb, Rami; Gul, Engin; Reece, Donna

Research article (journal) | Peer reviewed

Details about the publication

JournalFrontiers in Oncology
Volume12
Article number826342
StatusPublished
Release year2022 (18/02/2022)
Language in which the publication is writtenEnglish
DOI10.3389/fonc.2022.826342
Keywordsdaratumumab (DARA); lenalidomide; maintenance; multiple myeloma; relapsed/refractory

Authors from the University of Münster

Eisfeld, Christine
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)